Enrollment is behind, so the plan is to add clinical research sites. It feels like progress. It looks like a fix. It’s also the most expensive way to stay exactly where you are. Adding sites is a rational instinct. When the timeline slips and the board wants a number, expanding the network is the fastest lever available. But the instinct rests on an assumption: more sites means more patients, faster. The data disagrees.